Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
The purpose of the work was to study the impact of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH1), on atherosclerosis in subtotally nephrectomized (SNX) ApoE-deficient mice. Male DDAH1...
Main Authors: | Johannes Jacobi, Renke Maas, Michaela Arend, Nada Cordasic, Karl F. Hilgers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/4/5522 |
Similar Items
-
Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
by: Tan C, et al.
Published: (2021-12-01) -
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
by: Tzong-Shyuan Lee, et al.
Published: (2021-10-01) -
Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
by: Gabor Tajti, et al.
Published: (2018-01-01) -
Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
by: Müfide Arzu Özkarafakılı, et al.
Published: (2022-06-01) -
Renal asymmetric dimethylarginine inhibits fibrosis
by: Ming Wu, et al.
Published: (2020-10-01)